Clinical Validation of the New Print on Focus DAILIES Toric
1 other identifier
interventional
280
0 countries
N/A
Brief Summary
The purpose of this study is to validate the improvements to the inversion indicator.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2010
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2010
CompletedFirst Submitted
Initial submission to the registry
March 31, 2010
CompletedFirst Posted
Study publicly available on registry
April 2, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2010
CompletedResults Posted
Study results publicly available
June 27, 2011
CompletedJuly 10, 2012
January 1, 2012
2 months
March 31, 2010
May 27, 2011
June 26, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
Visibility of the Inversion Indicator on Lens When Lens Was on Participant's Finger, for Example, During Lens Insertion.
As assessed by the participant retrospectively after one week of wear and recorded on a questionnaire as a yes or no response to the question, "Did you notice an OK mark on the study lens while it was on your finger, for example, during lens insertion?" The positive "yes" responses are reported.
1 week
Study Arms (3)
nelfilcon A, modified inversion indicator
EXPERIMENTALNelfilcon A investigational contact lenses worn in both eyes on a daily wear, daily disposable basis for one week
nelfilcon A, no inversion indicator
EXPERIMENTALNelfilcon A investigational contact lenses worn in both eyes on a daily wear, daily disposable basis for one week
nelfilcon A, inversion indicator
ACTIVE COMPARATORNelfilcon A commercially marketed contact lenses worn in both eyes on a daily wear, daily disposable basis for one week.
Interventions
Investigational, nelfilcon A, toric, soft contact lens for daily disposable wear, with modified inversion indicator
Investigational, nelfilcon A, toric, soft contact lens for daily disposable wear, with no inversion indicator
Commercially marketed, nelfilcon A, toric, soft contact lens for daily disposable wear, with inversion indicator
Eligibility Criteria
You may qualify if:
- Be of legal age and sign written Informed Consent Document. If under legal age, parent or guardian must sign Informed Consent Document and subjects ages 12 through 17 must sign Informed Assent.
- Willing and able to wear study lenses in both eyes in the available parameters.
- Light-eyed subjects.
- Able to achieve 20/40 or better distance visual acuity (VA) in each eye at time of dispensing.
- Optimal or acceptable fit in each eye at time of dispensing.
- Willing to wear the study lenses at least 8 hours a day, 5 days a week.
You may not qualify if:
- Eye injury or surgery within twelve weeks prior to enrollment for this trial.
- Pre-existing ocular irritation that would preclude contact lens fitting.
- Currently enrolled in an ophthalmic clinical trial.
- Evidence of systemic or ocular abnormality, infection or disease which is likely to affect successful wear of contact lenses or use of their accessory solutions as determined by the investigator.
- Any use of medications for which contact lens wear could be contraindicated as determined by the investigator.
- RGP contact lens wearer.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- CIBA VISIONlead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs
- Organization
- CIBA VISION
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 31, 2010
First Posted
April 2, 2010
Study Start
March 1, 2010
Primary Completion
May 1, 2010
Study Completion
May 1, 2010
Last Updated
July 10, 2012
Results First Posted
June 27, 2011
Record last verified: 2012-01